Databases Company in the public registers

GEM - PHARM, spol. s r.o.

Active

Basic details

Company ID (IČO)
36598607
Tax ID (DIČ)
2022071667
VAT ID (IČ DPH)
SK2022071667
VAT
Registered for VAT under §4 since 1/12/2005
Registered office
Albinovská 644/14, 07801 Sečovce
Legal form
Spoločnosť s ručením obmedzeným
Register entry
Obchodný register Mestského súdu Košice, oddiel Sro, vložka 17180/V
Employees
3-4 zamestnanci
Established
13/10/2005

Financial data

From the financial statements in the Register of Financial Statements (RÚZ), in euros, for the last 5 years (each column is one fiscal year). Not verified; shown as the company filed them.

In 2025, GEM - PHARM, spol. s r.o. decreased its revenue by 3% to €465,647 and made a loss of €2,438. Equity fell by 6% to €44,283 and the debt ratio rose to 67.41%.

Revenue

GEM - PHARM, spol. s r.o.

YearRevenue
2021€424,074
2022€506,738
2023€466,469
2024€480,623
2025€465,647

Profit

GEM - PHARM, spol. s r.o.

YearProfit
2021€1,677
2022€1,803
2023€1,702
2024€5,287
2025−€2,438
2025
Revenue
€465,647
Profit
−€2,438
Assets
€135,879
Equity and liabilities
€135,879
Equity
€44,283
Debt ratio What it shows: How much of its assets the company finances with borrowed funds.
How it is computed: (Liabilities + Accruals) / Assets
67.41%
Gross margin What it shows: The share of revenue left after the cost of goods, materials, energy and services.
How it is computed: Value added / Revenue
11.42%

Financial statements as PDF

The files open in the Register of Financial Statements (RÚZ) in a new tab.

Assets

GEM - PHARM, spol. s r.o.

As of 31/12/2025

  • €135,879 · 100.00%

Equity and liabilities

GEM - PHARM, spol. s r.o.

As of 31/12/2025

  • €135,879 · 100.00%

Total income

GEM - PHARM, spol. s r.o.

YearSales of goods, products and servicesOther operating incomeInterest incomeTotal
2021€424,074€2,601€1€426,676
2022€506,738€1,807€1€508,546
2023€466,469€2,197€1€468,667
2024€480,623€148€3€480,774
2025€465,647€132€2€465,781

Costs

GEM - PHARM, spol. s r.o.

YearCost of goods soldMaterials and energyServicesPersonnel costsDepreciationOther operating costsFinancial costsIncome taxTotal
2021€353,486€7,962€26,746€28,735€1,714€2,918€2,812€626€424,999
2022€412,722€15,379€40,161€28,384€4,115€2,640€2,287€1,055€506,743
2023€378,058€10,596€33,054€34,221€4,115€2,787€3,093€1,041€466,965
2024€365,568€11,839€36,791€49,483€4,115€2,327€3,444€1,920€475,487
2025€366,338€9,791€36,354€43,700€2,400€4,072€3,644€1,920€468,219

Margins

GEM - PHARM, spol. s r.o.

YearGross marginOperating marginNet margin
20218.46%1.21%0.40%
20227.59%1.02%0.36%
20239.60%1.25%0.36%
202413.82%2.22%1.10%
202511.42%0.67%−0.52%

Year-on-year change

GEM - PHARM, spol. s r.o.

YearRevenueProfit
2021−9%379%
202220%8%
2023−8%−6%
20243%211%
2025−3%−146%

Financing structure

GEM - PHARM, spol. s r.o.

YearEquityProvisionsLoans and assistanceLong-term liabilitiesShort-term liabilities
2021€38,394€6,413€10,389−€1,595€81,811
2022€40,198€1,484€0−€1,479€100,511
2023€41,900€1,904€17,135−€1,353€86,332
2024€47,219€1,719€18,620−€3,309€69,389
2025€44,283€2,528€24,032−€5,343€70,379

Income tax

GEM - PHARM, spol. s r.o.

YearIncome taxCurrent tax
2021€626€626
2022€1,055€1,055
2023€1,041€1,041
2024€1,920€1,920
2025€1,920€1,920

Data sources

We take the data from the public registers as they publish it, unchanged and untranslated. FinPOST is an information website and does not verify the data. This page may be up to 7 days old. How we handle the data (privacy policy, section 3.9)